ID   BC-DS
AC   CVCL_WX21
SY   BCap37-Dose Stimulated
DR   Wikidata; Q93423704
RX   PubMed=26782109;
CC   Problematic cell line: Contaminated. Parent cell line (BCaP-37) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 43.8 +- 3.3 hours (PubMed=26782109).
CC   Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0164 ! BCaP-37
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
RX   PubMed=26782109; DOI=10.3892/or.2016.4566;
RA   Xu M.-J., Jiang D.-H., Shen J.-Y., Zheng H.-L., Fan W.-M.;
RT   "Distinct characterization of two vinorelbine-resistant breast cancer
RT   cell lines developed by different strategies.";
RL   Oncol. Rep. 35:2355-2363(2016).
//